Saccharomyces boulardii in childhood (European Journal of Pediatrics (2009 March) 168:3 (253-65) DOI: 10.1007/s00431-008-0879-7);Saccharomyces boulardii in childhood

European Journal of Pediatrics

Volumn 168, Issue 3, 2009, Pages 253-265

  Vandenplas, Yvan ^a   Brunser, Oscar ^b   Szajewska, Hania ^c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF CHILE   (Chile)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Child; Diarrhea; Gastroenteritis; Probiotic; Saccharomyces boulardii; Yeast

Indexed keywords

BACTERIAL TOXIN; PROBIOTIC AGENT;

ACUTE GASTROENTERITIS; ANTIINFLAMMATORY ACTIVITY; CHILD; CLINICAL TRIAL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENTERITIS; HELICOBACTER INFECTION; HUMAN; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MYCOSIS; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES BOULARDII; TRAVELLER DIARRHEA; TREATMENT INDICATION;

EID: 59449087882     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-009-0947-7     Document Type: Erratum

References (91)

1. H Andersson NG Asp A Bruce 2001 Health effects of probiotics and prebiotics. A literature review on human studies Scand J Nutr 45 58 95
2. F Barbut JL Meynard M Guiguet 1997 Clostridium difficile-associated diarrhea in HIV infected patients: epidemiology and risk factors J Acq Immun Def Synd 16 176 181
3. JG Bartlett TW Chang M Gurwith 1978 Antibiotic-associated pseudomembranous colitis due to toxin producing Clostridia N Engl J Med 298 531 534
4. JG Bartlett 2002 Clinical practice. Antibiotic-associated diarrhea N Engl J Med 346 334 339
5. S Bassetti R Frei W Zimmerli 1998 Fungemia with Saccharomyces cerevisiae after treatment with S. boulardii Am J Med 105 71 72
6. D Baumgart 2007 The probiotic yeast Saccharomyces boulardii inhibits DC-induced activation of naïve T-cells Gastroenterology 135 4 A 559
7. PH Benhamou P Berlier G Danjou 1999 Antibiotic-associated diarrhoea in children: a computer monitored double-blind outpatients trial comparing a protective and a probiotic agent Med Chir Dig 28 163 168
8. MF Bernet D Brassart JR Neeser 1994 Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria Gut 35 483 489
9. SJ Bhatia N Kochar P Abraham 1989 Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro J Clin Microbiol 27 2328 2330
10. AG Billoo MA Memon SA Khaskheli G Murtaza K Iqbal M Saeed Shekhani AQ Siddiqi 2006 Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea World J Gastroenterol 12 4557 4560
11. H Bléhaut J Massot GW Elmer 1989 Disposition kinetics of Saccharomyces boulardii in man and rat Biopharm Drug Dispos 10 353 364
12. G Breves K Faul B Schröder 2000 Application of the colon-stimulation technique for studying the effects of Saccharomyes boulardii on basic parameters of porcine cecal microbial metabolism disturbed by Clindamycin Digestion 61 193 200
13. Brunser O (2009) Coincubation of Saccharomyces boulardii with Helicobacter pylori. A Morphological Study (in press)
14. O Burkhardt T Köhnlein M Pletz 2005 Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole Scand J Infect Dis 37 69 72
15. JP Buts P Bernasconi JP Vaerman 1990 Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii Dig Dis Sci 35 251 256
16. JP Buts P Bernasconi MP Van Craynest 1986 Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii Pediatr Res 20 192 196
17. JP Buts G Corthier M Delmee 1993 Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants J Pediatr Gastroenterol Nutr 16 419 425
18. JP Buts N De Keyser L De Raedemaeker 1994 Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines Pediatr Res 36 522 527
19. JP Buts B Duranton N De Keyser 1998 Premature stimulation of rat sucrase-isomaltase (SI) by exogenous insulin and the analog B-Asp10 is regulated by a receptor-mediated signal triggering SI gene transcription Pediatr Res 43 585 591
20. JP Buts N De Keyser S Marandi 1999 Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats Gut 45 89 96
21. JP Buts N De Keyser C Stilmant 2002 Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease Pediatr Res 51 528 534
22. JP Buts N Dekeyser C Stilmant 2006 Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation Pediatr Res 60 24 29
23. RB Canani P Cirillo GA Terrin 2007 Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations BMJ 335 340 347
24. I Castagliuolo JT LaMont ST Nikulasson 1996 Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum Infect Immun 12 5225 5232
25. I Castagliuolo MF Riegler L Valenick 1999 Saccharomyces boulardii protease mediates Clostridium difficile toxin A and B effects in human colonic mucosa Infect Immun 67 302 307
26. C Castaneda E Garcia M Santa Cruz M Fernandez P Monterrey 1995 Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis Rev Mex Pueric Pediatr 2 12 16
27. G Cetina-Sauri GS Busto 1994 Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea Ann Ped 6 397 400
28. M Cindoruk G Erkan T Karakan 2007 Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study Helicobacter 12 309 316
29. D Czerucka S Dahan B Mograbi 2000 Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells Infect Immun 68 5998 6004
30. D Czerucka T Piche P Rampal 2007 Review article: yeast as probiotics-Saccharomyces boulardii Aliment Pharmacol Ther 26 767 778
31. D Czerucka P Rampal 2002 Experimental effects of Saccharomyces boulardii on diarrheal pathogens Microbes Infect 4 733 739
32. D Czerucka I Roux P Rampal 1994 Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3, 5-cyclic monophosphate induction in intestinal cells Gastroenterology 106 65 72
33. S Dahan G Dalmasso V Imbert 2003 Saccharomyces boulardii interfers with enterohemorragic Escherichia coli-induced signaling pathways in T84 cells Infect Immun 71 766 773
34. G Dalmasso F Cottrez V Imbert 2006 Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes Gastroenterology 131 1812 1825
35. G Dalmasso A Loubat S Dahan 2006 Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells Res Microbiol 157 456 465
36. R de Llanos A Querol J Pemán 2006 Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections Int J Food Microbiol 110 286 289
37. Desreumeaux P, Rousseaux C (2006) Influence of the intestinal microflora on host immunity in inflammatory bowel disease. In G. Microflora Ed. John Libbey Eurotext
38. DG Duman S Bor O Ozütemiz 2005 Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication Eur J Gastroenterol Hepatol 17 1357 1361
39. GW Elmer G Corthier 1991 Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice Can J Microbiol 37 315 317
40. GW Elmer LV McFarland CM Surawicz 1999 Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients Aliment Pharmacol Ther 13 1663 1668
41. GW Elmer KA Moyer R Vega 1995 Evaluation of Saccharomyces boulardii for patients with HIV-related chronic diarrhoea and in healthy volunteers receiving antifungals Microecol and Ther 25 23 31
42. CL Elstner AN Lindsay LS Book 1983 Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children Pediatr Inf Dis 2 364 366
43. O Erdeve U Tiras Y Dallar 2004 The probiotic effect of Saccharomyces boulardii in a pediatric age group J Trop Pediatr 50 234 236
44. FAO/WHO (2006) Probiotics in Food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition Paper 85 ( ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf )
45. JLR Fietto RS Araújo FN Valadão 2004 Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii Can J Microbiol 50 615 621
46. D Gaon H Garcia L Winter 2003 Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children Medicina (B Aires) 63 293 298
47. BR Gedek 1999 Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii Mycoses 42 261 264
48. MF Geyik M Aldemir S Hosoglu 2006 The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice Ann R Coll Surg Engl 88 176 180
49. P Girard Y Pansart I Lorette 2003 Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats Dig Dis Sci 48 770 774
50. CG Goldman DA Barrado N Balcarce 2006 Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children Nutrition 22 984 988
51. M Gotteland L Poliak S Cruchet 2005 Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori Acta Paediatr 94 1747 1751
52. C Graf G Gavazzi 2007 Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation J Infect 54 310 311
53. A Guarino F Albano S Ashkenazi 2008 The ESPGHAN/ESPID Guidelines for the Management of Acute Gastroenteritis in Children in Europe J Pediatr Gastroenterol Nutr 46 S81 S122
54. A Hafeez P Tariq S Ali 2002 The efficacy of Saccharomyces boulardii in the treatment of acute watery diarrhea in children: a multicentre randomized controlled trial J Coll Phys Surg Pakist 12 432 434
55. C Hennequin C Kauffman-Lacroix A Jobert 2000 Possible role of catheters in Saccharomyces boulardii fungemia Eur J Clin Microbiol Infect Diseases 19 16 20
56. C Hennequin A Thierry GF Richard 2001 Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains J Clin Microbiol 39 551 559
57. O Herek IG Kara I Kaleli 2004 Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury Surg Today 34 256 260
58. K Htwe KS Yee M Tin Y Vandenplas 2008 Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study Am J Trop Med Hyg 78 214 216
59. CA Janeway Jr R Medzhitov 2002 Innate immune recognition Annu Rev Immunol 20 197 216
60. S Jawhara D Poulain 2007 Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis Med Mycol 45 691 700
61. SM Klein GW Elmer LV McFarland 1993 Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers Pharm Res 10 1615 1619
62. M Kotowska P Albrecht H Szajewska 2005 Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther 21 583 590
63. Z Kurugol G Koturoglu 2005 Effects of Saccharomyces boulardii in children with acute diarrhoea Acta Paediatr 94 44 47
64. E Lionetti VL Miniello SP Castellaneta 2006 Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial Aliment Pharmacol Ther 24 1461 1468
65. MD Luyer WA Buurman M Hadfoune 2005 Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock Infect Immun 73 3686 3692
66. S Mathur R Singh 2005 Antibiotic resistance in food lactic acid bacteria-a review Int J Food Microbiol 105 281 295
67. LV McFarland CM Surawicz WE Stamm 1990 Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients J Infect Dis 162 678 684
68. LV McFarland 1998 Epidemiology, risk factors and treatments for antibiotic-associated diarrhea Dig Dis 16 292 307
69. KL Mumy X Chen CP Kelly 2008 Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events Am J Physiol Gastrointest Liver Physiol 294 G599 G609
70. P Muñoz E Bouza M Cuenca-Estrella 2005 Saccharomyces cerevisiae fungemia: an emerging infectious disease Clin Infect Dis 40 1625 1634
71. S Piechno P Seguin JP Gangneux 2007 Saccharomyces boulardii fungal sepsis: beware of the yeast Can J Anaesth 54 245 246
72. C Pothoulakis CP Kelly MA Joshi 1993 Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum Gastroenterology 104 1108 1115
73. Riedel BD, Ghishan FK (1996) Acute diarrhea. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB (eds) Pediatric gastrointestinal disease, 2nd edn. Mosby-Year Book Inc., St. Louis, pp 251-262
74. MC Rigothier J Maccario PN Vuong 1990 Effects of Saccharomyces boulardii yeast on trophozoites of Entamoeba histolytica in vitro and in cecal amebiasis in young rats Ann Parasitol Hum Comp 65 51 60
75. BJA Rijnders E Van Wijngaerden C Verwaest 2000 Saccharomyces fungemia complicating S. boulardii treatment in a non-immunocompromised host Intensive Care Med 26 825
76. ACP Rodrigues RM Nardi EA Bambirra 1996 Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri conventional and gnotobiotic mice J Appl Bacteriol 91 251 256
77. SM Schneider F Girard-Pipau J Filippi 2005 Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition World J Gastroenterol 11 6165 6169
78. S Sougioultzis S Simeonidis KR Bhaskar 2006 Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression Biochem Biophys Res Commun 343 69 76
79. J Sykora K Valeckova J Amlerova 2005 Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study J Clin Gastroenterol 39 692 698
80. H Szajewska M Setty J Mrukowicz 2006 Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy J Pediatr Gastroenterol Nutr 42 454 475
81. H Szajewska A Skórka M Dylag 2007 Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children Aliment Pharmacol Ther 25 257 264
82. R Temmerman B Pot G Huys 2003 Identification and antibiotic susceptibility of bacterial isolates from probiotic products Int J Food Microbiol 81 1 10
83. JL Tong ZH Ran J Shen 2007 Meta-analysis: the effect of supplementation with probiotics on eradication rates and side effects during Helicobacter pylori eradication therapy Aliment Pharmacol Ther 25 155 168
84. D Turck JP Bernet J Marx 2003 Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population J Pediatr Gastroenterol Nutr 37 22 26
85. Y Vandenplas S Salvatore M Vieira 2007 Probiotics in infectious diarrhoea in children: are they indicated? Eur J Pediatr 166 1211 1218
86. G Villarruel DM Rubio F Lopez 2007 Saccharomyces boulardii in acute childhood diarrhea: a randomized controlled study Acta Paediatr 96 538 541
87. WHO (2003) The treatment of diarrhoea. A manual for physicians and other senior health workers. WHO/CAH/03.7 10/03
88. WHO (1995) The treatment of diarrhea. A manual for physicians and other senior health workers; WHO/CDR/95.3. Geneva, World Health Organization
89. J Wiström SR Norrby EB Myhre 2001 Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study J Antimicrob Chemother 47 43 50
90. X Wu BA Vallance L Boyer 2008 Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors Am J Physiol Gastrointest Liver Physiol 294 G295 G306
91. P Zunic J Lacotte M Pegoix 1991 S. boulardii fungemia. Apropos of a case Therapie 46 498 499